Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gaillard

Showing results (31-40 of 426) with videos related to

Pageof 43
Sort By:
Acta Endocrinologica|November 1, 1988
Hormonal effects of CQP 201-403, a new dopamine agonistR C Gaillard, J Brownell
Journal Francais D'Oto-Rhino-Laryngologie, Audio-Phonologie Et Chirurgie Maxillo-Faciale|September 1, 1970
[Acoustic study of recurrent paralysis]G Cornut, M C Gaillard
Domestic Animal Endocrinology|October 24, 1998
Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphismR C Gaillard, E Spinedi
Endocrinology|September 2, 1998
A regulatory loop between the hypothalamo-pituitary-adrenal (HPA) axis and circulating leptin: a physiological role of ACTHE Spinedi, R C Gaillard
Therapie|September 1, 1979
[Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)]C Gaillard-Sizaret, P Gaillard
Revue Medicale Suisse|March 25, 2005
[Genetics of multiple endocrine neoplasies: clinical implications]P Igaz, R C Gaillard
Life Sciences|January 1, 1988
Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist propertiesR C Gaillard, J Brownell
Jamba (Potchefstroom, South Africa)|April 18, 2024
Post-disaster research: Is there gold worth the rush?J C Gaillard, Christopher Gomez
Nature|November 22, 2019
Disaster-zone research needs a code of conductJ C Gaillard, Lori Peek
Annales D'Endocrinologie|January 1, 1983
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis]R C Gaillard, W Herrmann
Pageof 43

Showing results (31-40 of 426) with videos related to

Sort By:
Pageof 43
Acta Endocrinologica|November 1, 1988
Hormonal effects of CQP 201-403, a new dopamine agonistR C Gaillard, J Brownell
Journal Francais D'Oto-Rhino-Laryngologie, Audio-Phonologie Et Chirurgie Maxillo-Faciale|September 1, 1970
[Acoustic study of recurrent paralysis]G Cornut, M C Gaillard
Domestic Animal Endocrinology|October 24, 1998
Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphismR C Gaillard, E Spinedi
Endocrinology|September 2, 1998
A regulatory loop between the hypothalamo-pituitary-adrenal (HPA) axis and circulating leptin: a physiological role of ACTHE Spinedi, R C Gaillard
Therapie|September 1, 1979
[Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)]C Gaillard-Sizaret, P Gaillard
Revue Medicale Suisse|March 25, 2005
[Genetics of multiple endocrine neoplasies: clinical implications]P Igaz, R C Gaillard
Life Sciences|January 1, 1988
Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist propertiesR C Gaillard, J Brownell
Jamba (Potchefstroom, South Africa)|April 18, 2024
Post-disaster research: Is there gold worth the rush?J C Gaillard, Christopher Gomez
Nature|November 22, 2019
Disaster-zone research needs a code of conductJ C Gaillard, Lori Peek
Annales D'Endocrinologie|January 1, 1983
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis]R C Gaillard, W Herrmann
Pageof 43